Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric M Yoshida

Showing results (201-210 of 341) with videos related to

Pageof 35
Sort By:
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|August 15, 2008
Outcomes of peginterferon alpha-2a and ribavirin hepatitis C therapy in Aboriginal CanadiansCurtis L Cooper, Robert J Bailey, Vince G Bain, et al.
Canadian Liver Journal|July 18, 2025
Severe acute allograft rejection 22 years after liver transplantationMonica Dahiya, Michael Minkley, Daniel R Owen, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|April 17, 2008
The use of budesonide in the treatment of autoimmune hepatitis in CanadaIman Zandieh, Darin Krygier, Victor Wong, et al.
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|August 18, 2018
In-hospital post-transplant acute hepatitis A viral (HAV) infection in a liver transplant recipient who was HAV seropositive pre-transplantJulie Zhu, Fatema Alalkim, Trana Hussaini, et al.
Frontiers in Medicine|February 3, 2022
Epidemiology and Risk Factors of Portal Venous System Thrombosis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-AnalysisHanyang Lin, Zhaohui Bai, Fanjun Meng, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|October 10, 2009
The use of endoscopic ultrasonography and other imaging modalities in the preoperative staging of rectal villous tumours: a case of overstaging by magnetic resonance imagingMichelle C Buresi, Iman Zandieh, Alexander G Nagy, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|March 19, 2005
Treatment of chronic hepatitis C in Canadian prison inmatesJohn D Farley, Victor K Wong, Henry V Chung, et al.
Future Oncology (London, England)|March 16, 2018
Insights into the hepatocellular carcinoma patient journey: results of the first global quality of life surveyJennifer Gill, Andrei Baiceanu, Paul J Clark, et al.
Annals of Hepatology|September 6, 2007
Fatal hepatitis C associated fibrosing cholestatic hepatitis as a complication of cyclophosphamide and corticosteroid treatment of active glomerulonephritisFaisal Saleh, Hin Hin Ko, Jennifer E Davis, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|July 18, 2013
In a 'real-world', clinic-based community setting, sorafenib dose of 400 mg/day is as effective as standard dose of 800 mg/day in patients with advanced hepatocellular carcimona, with better tolerance and similar survivalAlexandra Shingina, Al Moutaz Hashim, Mazhar Haque, et al.
Pageof 35

Showing results (201-210 of 341) with videos related to

Sort By:
Pageof 35
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|August 15, 2008
Outcomes of peginterferon alpha-2a and ribavirin hepatitis C therapy in Aboriginal CanadiansCurtis L Cooper, Robert J Bailey, Vince G Bain, et al.
Canadian Liver Journal|July 18, 2025
Severe acute allograft rejection 22 years after liver transplantationMonica Dahiya, Michael Minkley, Daniel R Owen, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|April 17, 2008
The use of budesonide in the treatment of autoimmune hepatitis in CanadaIman Zandieh, Darin Krygier, Victor Wong, et al.
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|August 18, 2018
In-hospital post-transplant acute hepatitis A viral (HAV) infection in a liver transplant recipient who was HAV seropositive pre-transplantJulie Zhu, Fatema Alalkim, Trana Hussaini, et al.
Frontiers in Medicine|February 3, 2022
Epidemiology and Risk Factors of Portal Venous System Thrombosis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-AnalysisHanyang Lin, Zhaohui Bai, Fanjun Meng, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|October 10, 2009
The use of endoscopic ultrasonography and other imaging modalities in the preoperative staging of rectal villous tumours: a case of overstaging by magnetic resonance imagingMichelle C Buresi, Iman Zandieh, Alexander G Nagy, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|March 19, 2005
Treatment of chronic hepatitis C in Canadian prison inmatesJohn D Farley, Victor K Wong, Henry V Chung, et al.
Future Oncology (London, England)|March 16, 2018
Insights into the hepatocellular carcinoma patient journey: results of the first global quality of life surveyJennifer Gill, Andrei Baiceanu, Paul J Clark, et al.
Annals of Hepatology|September 6, 2007
Fatal hepatitis C associated fibrosing cholestatic hepatitis as a complication of cyclophosphamide and corticosteroid treatment of active glomerulonephritisFaisal Saleh, Hin Hin Ko, Jennifer E Davis, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|July 18, 2013
In a 'real-world', clinic-based community setting, sorafenib dose of 400 mg/day is as effective as standard dose of 800 mg/day in patients with advanced hepatocellular carcimona, with better tolerance and similar survivalAlexandra Shingina, Al Moutaz Hashim, Mazhar Haque, et al.
Pageof 35